KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Emergent BioSolutions (EBS) Depreciation and Depletion (2021 - 2026)

Emergent BioSolutions has reported Depreciation and Depletion over the past 6 years, most recently at $7.0 million for Q1 2026.

  • For Q1 2026, Depreciation and Depletion fell 23.08% year-over-year to $7.0 million; the TTM value through Mar 2026 reached $28.6 million, down 30.41%, while the annual FY2025 figure was $30.7 million, 29.75% down from the prior year.
  • Depreciation and Depletion for Q1 2026 was $7.0 million at Emergent BioSolutions, down from $7.2 million in the prior quarter.
  • Over five years, Depreciation and Depletion peaked at $28.5 million in Q2 2022 and troughed at $7.0 million in Q1 2026.
  • A 5-year average of $13.2 million and a median of $11.7 million in 2023 define the central range for Depreciation and Depletion.
  • Biggest five-year swings in Depreciation and Depletion: soared 54.05% in 2022 and later crashed 42.36% in 2023.
  • Year by year, Depreciation and Depletion stood at $18.0 million in 2022, then decreased by 25.56% to $13.4 million in 2023, then decreased by 27.61% to $9.7 million in 2024, then decreased by 25.77% to $7.2 million in 2025, then dropped by 2.78% to $7.0 million in 2026.
  • Business Quant data shows Depreciation and Depletion for EBS at $7.0 million in Q1 2026, $7.2 million in Q4 2025, and $7.1 million in Q3 2025.